Health Care & Life Sciences » Biotechnology | Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
54.13 M
Public Float
29.72 M
Accelerate Diagnostics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.65
Market Cap
$1.28 B
Shares Outstanding
54.46 M
Public Float
29.78 M

Profile

Address
3950 South Country Club Road
Tucson Arizona 85714
United States
Employees -
Website http://acceleratediagnostics.com
Updated 07/08/2019
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

Financials

View All

Lawrence L. Mehren
President, Chief Executive Officer & Director
John Patience
Chairman